Composite material for repairing critical large and small bone defects and preparation method thereof
By synthesizing Zn/Mg co-doped HA in bone defect repair materials and combining it with PCL, porous composite scaffolds were prepared, which solved the problem that existing materials were difficult to promote vascular and bone formation at the same time, and achieved effective use of critical bone defects of small size Repair provides a theoretical basis for clinical application.
Patent Information
- Application Number
- CN202411143803.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-20
- Publication Date
- 2024-11-26
AI Technical Summary
Existing bone defect repair materials are difficult to effectively promote the formation of blood vessels and bones at the same time, and few studies on co-doping HA of magnesium and zinc limit their application in critically small and small bone defect repair.
Zn/Mg co-doped HA is synthesized under specific molar ratios and pH conditions, combining 1,2,3,4,5, etc. 6-cyclohexane hexacarboxylic acid monohydrate and polycaprolactone PCL were prepared by 3D printing to prepare a porous composite scaffold material for critical small and small bone defect repair.
This method can effectively promote the generation of blood vessels and bones, improve bone healing efficiency, and achieve effective repair of critical large and small bone defects through the synergistic effect of Mg and Zn, providing a theoretical and practical basis for clinical application.
Smart Images

Figure CN119015513A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of biomedical materials, and in particular to a composite scaffold material capable of repairing critical-size bone defects by promoting the formation of blood vessels and bones, and a preparation method thereof. Background Art
[0002] Bone defects of critical size caused by trauma, bone tumors, infection and other diseases cannot repair themselves and require external intervention. At present, the treatment of critical size bone defect repair mainly includes autologous bone transplantation, allogeneic bone transplantation and artificial bone substitutes. Autologous bone transplantation is known for its high osteoinductivity and bone conductivity and is considered the "gold standard" for bone repair. However, its applicability is limited due to the scarcity of resources and the difficulty in accurately matching the size and shape of the defect. Allogeneic bone transplantation has the risk of immune rejection and even disease transmission, which limits its clinical application, while artificial bone transplantation has become the focus of researchers on bone defect repair materials due to its wide source and low immunogenicity. At present, various biomaterials are designed to repair bone defects, such as bioactive glass, porous ceramic scaffolds, metals, hydrogels, polymers and their composites.
[0003] Calcium phosphate (CaP) bioceramics, such as hydroxyapatite (HA), are widely used to repair bone defects throughout the body due to their chemical similarity to mammalian bones and teeth and good biocompatibility (usually used to fill hard tissue defects and coat implant surfaces). Among them, hydroxyapatite (HA), as the main inorganic component of human hard tissue, theoretically seems to be one of the most suitable materials for human bone tissue repair. HA has excellent osteoconductive and osteoinductive properties, which not only provides space and support framework for blood vessels and new bone growth, but also induces mesenchymal stem cells to differentiate into osteoblasts; thereby accelerating bone reconstruction, improving osteogenesis efficiency and bone integration effect. However, in fact, hydroxyapatite in natural human bone is composed of a mixed phase containing a calcium-phosphorus phase that deviates from the ideal chemical ratio (Ca / P=1.67) and trace element doping. Therefore, the chemical composition of HA synthesized according to the ideal chemical ratio is simple and insufficient to meet clinical needs. Therefore, different methods need to be used to modify HA to give it the required biological functions. Trace element doping is one of the most common HA modification technologies at present, which can be roughly divided into cation doping and anion doping. These trace elements have unique biological functions. For example, boron ions can upregulate the expression of osteogenic differentiation markers (BMP, etc.), and induce osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs). Copper ions can stimulate stem cells to secrete VEGF and promote angiogenesis. In addition, in the rat skull defect model, bone regeneration in the copper-containing group was significantly improved compared with the control group. Silicon ions can regulate the coupling of osteogenesis and angiogenesis, create a beneficial immune microenvironment at the bone defect site, and achieve vascularized bone regeneration. Doping with divalent or multivalent ions (such as Zn2+ or Si 4+ Doped HA nanoparticles) can improve the biocompatibility of composites and promote osteogenic differentiation and stable bonding of tissue-material interfaces. 2+ or Mg 2+ ) induces bone marrow mesenchymal stem cells to synthesize and secrete VEGF and other angiogenic factors, thereby further accelerating the induction of angiogenesis in vitro or in vivo.
[0004] It is noteworthy that magnesium, an essential human element, possesses many beneficial biological effects and plays a key role in bone metabolism. Magnesium deficiency is highly associated with osteoporosis. Magnesium deficiency can upregulate the expression of tumor necrosis factor (TNF-α), interleukin-1 (IL-1β), and receptor activator of nuclear factor kappa-B ligand (RANKL), and downregulate the expression of osteoprotegerin (OPG), accelerate bone resorption and induce osteoporosis. In addition, Mg can enhance angiogenesis through the CGRP-FAK-VEGF signaling pathway mediated by CGRP to repair critical-sized bone defects. Zinc is also abundant in bones and is a key element for bone metabolism. It increases the activity of alkaline phosphatase (ALP) in bone marrow mesenchymal stem cells, which further induces osteogenic differentiation and stimulates bone development and mineralization. Zinc can inhibit the formation of osteoclasts to a certain extent and promote bone healing. In addition, zinc has an antibacterial effect, especially against Staphylococcus aureus, lactic acid bacteria, and Gram-positive bacteria, and its antibacterial property is positively correlated with the zinc doping molar fraction. Compared with single element (Mg and Zn ion) doped HA, relatively few studies have been conducted on Mg and Zn co-doped HA. In addition, some prevalent studies on dual-doped HA mainly investigated physical properties such as lattice and crystal size after doping, but were limited in exploring their effects on biological domains (cells, such as osteoblast-related cells). Therefore, further studies are needed to investigate the synergistic effects of Mg and Zn co-doping on angiogenesis and osteogenesis. Summary of the invention
[0005] In order to solve the above problems, the present invention provides a composite material for repairing critical-size bone defects and a preparation method thereof.
[0006] The present invention includes the following technical solutions:
[0007] A method for preparing a composite material for repairing critical size bone defects comprises the following steps:
[0008] 1) Ca(NO3)2, Zn(NO3)2, Mg(NO3)3 and Na2HPO4 are added into deionized water and dissolved completely so that the molar ratio of (Ca+Zn+Mg) / P in the solution is 1-2;
[0009] 2) adjusting the pH of the solution in step 1) to between 2 and 3 with an acid, and then adding an appropriate amount of 1,2,3,4,5,6-cyclohexanehexacarboxylic acid monohydrate H6L. After H6L is completely dissolved, adding urea until it is completely dissolved;
[0010] 3) transferring the solution prepared in step 2) to a reactor for reaction at a temperature of 150-250° C. for 10-14 hours, collecting the precipitate after the reaction, washing the precipitate by centrifugation, and then repeatedly washing it with deionized water and anhydrous ethanol until the pH value reaches neutral, and drying it in an oven to obtain a powder;
[0011] 4) dissolving an appropriate amount of PCL in dichloromethane and stirring thoroughly, then dispersing the powder obtained in step 3) in the dichloromethane and stirring to form a uniform dispersion; obtaining the composite material for repairing critical-size bone defects.
[0012] Furthermore, in the above-mentioned method for preparing a composite material for repairing critical-size bone defects, in step 1), the molar ratio of Mg: (Zn+Mg+Ca) is 0.05-0.15; in some embodiments, it is preferably 0.1.
[0013] Furthermore, in the above method for preparing a composite material for repairing critical-size bone defects, in step 1), the molar ratio of Zn: (Zn+Mg+Ca) is less than 0.3, and in some embodiments, is preferably 0.1.
[0014] Further, in the above-mentioned method for preparing a composite material for repairing a critical size bone defect, the step 1) is performed by stirring, and finally Ca 2+ The concentration in solution is 0.05-0.2 M; in some embodiments, 0.1 M is preferred.
[0015] Furthermore, in the above-mentioned method for preparing a composite material for repairing critical-size bone defects, the final concentration of H6L in the solution in step 2) is 0.5-2 mM; in some embodiments, preferably 1 mM.
[0016] Furthermore, the method for preparing the composite material for repairing critical-size bone defects comprises the following steps:
[0017] 1) Add Ca(NO3)2, Zn(NO3)2, Mg(NO3)3 and Na2HPO4 into 150 mL of deionized water and dissolve completely to obtain a mixed solution; the molar ratio of (Ca+Zn+Mg) / P in the solution is 1.67, the molar ratio of Mg:(Zn+Mg+Ca) is 0.05-0.15, and the molar ratio of Zn:(Zn+Mg+Ca) is 0.1; Ca 2+ The concentration is 0.1M;
[0018] 2) The pH of the mixed solution was adjusted to 2.3 with acid, and H6L was added to a final concentration of 1 mM. After H6L was completely dissolved, urea was added to a final concentration of 0.56 M and dissolved;
[0019] 3) transferring the solution prepared in step 2) to a six-station polytetrafluoroethylene automatic autoclave for reaction at 200° C. for 12 h, centrifuging at 4000 rpm for 3 min after the reaction, collecting the precipitate, washing the obtained precipitate, and then repeatedly washing it with deionized water and anhydrous ethanol until the pH value reaches neutral, and drying it in an oven to obtain a powder;
[0020] 4) Dissolve 4.5 g of PCL in 40 ml of dichloromethane and stir thoroughly, then disperse 0.5 g of the powder prepared in step 3) in the dichloromethane solution and stir thoroughly to obtain the composite material for repairing critical size bone defects.
[0021] The invention discloses a composite material for repairing critical-size bone defects, which is obtained by the above-mentioned preparation method.
[0022] Furthermore, the present invention discloses the use of the composite material for repairing critical-size bone defects in preparing a three-dimensional scaffold, which is characterized in that it comprises the following steps:
[0023] The prepared composite material is extruded through a 0.1-1 mm conical plastic nozzle at a speed of 1-10 mm / s and a pressure of 0.1-0.3 MPa to obtain a porous three-dimensional scaffold; the scaffold is freeze-dried to remove the organic solvent.
[0024] Preferably, the three-dimensional scaffold is implanted in vivo and used for repairing critical-sized bone defects.
[0025] The present invention has the following beneficial effects:
[0026] The present invention discloses a composite scaffold material and a preparation method thereof that can repair critical-size bone defects by promoting the formation of blood vessels and bones. First, a Zn / Mg co-doped composite scaffold is prepared by the method disclosed in the present application, and the composite scaffold is implanted into a rat femoral defect model. The Mg element in the composite scaffold material has an angiogenesis-promoting effect, the Zn element has a bone healing-promoting and antibacterial effect, and HA has excellent bone conduction and bone induction properties. Then, a 1,2,3,4,5,6-cyclohexanehexacarboxylic acid monohydrate (H6L) small molecule template agent is added to make the synthesized HA into microspheres with uniform sphericity and regular morphology. Finally, polycaprolactone (PCL) that can maintain the scaffold morphology and mechanical properties is mixed as an ink, and a Zn / Mg co-doped composite scaffold material is prepared by 3D printing, thereby effectively repairing critical-size bone defects caused by diseases such as trauma, bone tumors, and infections, providing a theoretical and practical basis for the clinical application and transformation of Zn / Mg co-doped composite scaffold materials in repairing critical-size bone defects.
[0027] 2. The overall implementation process of this method is relatively simple, with a wide range of sources, strong operability, great market application potential, and is conducive to promotion and use. BRIEF DESCRIPTION OF THE DRAWINGS
[0028] Figure 1 Schematic diagram of the preparation and function of Zn / Mg@HA and Zn / Mg@HA-PCLs for angiogenesis and osteogenesis;
[0029] Figure 2 Characterization of HA, 10Zn@HA, 5Mg10Zn@HA, 10Mg10Zn@HA and 15Mg10Zn@HA; (A) SEM image and elemental mapping, (B) XRD pattern, (C) FTIR spectrum;
[0030] Figure 3 Characterization of HA-PCLs, 10Zn@HA-PCLs, 5Mg10Zn@HA-PCLs, 10Mg10Zn@HA-PCLs, and 15Mg10Zn@HA-PCLs, (A) SEM image, (B) elemental mapping of the cross section of 15Mg10Zn@HA-PCLs, (C) stress-strain curve, (D) elastic modulus, (n=3);
[0031] Figure 4In vitro angiogenesis ability of HA-PCLs, 10Zn@HA-PCLs, 5Mg10Zn@HA-PCLs, 10Mg10Zn@HA-PCLs and 15Mg10Zn@HA-PCLs, (A) proliferation activity of HUVECs in each group of scaffolds after 24h, 48h and 72h of culture, (B) statistical results of wound healing, (C) live / dead staining images of each group of scaffolds (scale bar = 500μm), (D) wound healing test of HUVECs in the presence of each group of scaffolds (scale bar = 100μm), (E) expression of angiogenesis-related genes in each group of scaffolds (VEGF, FLT1, KDR, bFGF);
[0032] Figure 5 The expression of angiogenesis-related proteins CD31 and VEGF in HUVECs at 24 h was detected by WB;
[0033] Figure 6 Cell viability and proliferation activity of bone marrow mesenchymal stem cells in each group of scaffolds, (A) proliferation activity after 1, 3, and 5 days of culture, (B) live / dead staining images of each group of scaffolds (scale bar = 500 μm);
[0034] Figure 7 In vitro osteogenic capacity of HA-PCLs, 10Zn@HA-PCLs, 5Mg10Zn@HA-PCLs, 10Mg10Zn@HA-PCLs, and 15Mg10Zn@HA-PCLs, (A) cells cultured for 7 and 14 days were stained with alkaline phosphatase (ALP), (scale bar = 200 μm) (B) on day 21, cells were stained with Alizarin Red S (ARS) (scale bar = 500 μm), (C) ALP activity of cells cultured for 7 days, (D) quantification of cell mineralization on day 21, (E) expression of osteogenic-related genes in each group of scaffolds (OPN, cyanate, ALP, RUNX2);
[0035] Figure 8 WB was used to detect the expression of osteogenic-related proteins OCN, OPN, ALP, RUNX2, and COL I in 14-day BMSCs;
[0036] Fig. 9 H&E and Masson staining of bone formation after 1 month and 3 months of composite scaffold implantation; S represents scaffold, N represents new bone; scale bar 1000μm, scale bar for magnified area 400μm. DETAILED DESCRIPTION
[0037] The technical solutions in the embodiments of the present invention are described clearly and completely below. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0038] The reagents or instruments used in the examples of the present invention without indicating the manufacturer are all conventional reagent products that can be obtained through commercial purchase.
[0039] Example 1
[0040] Preparation and characterization of 3D printed composite scaffolds after element doping with HA
[0041] Zn-doped HA and Zn / Mg co-doped HA were synthesized via hydrothermal synthesis, and then the element-doped HA-PCL composite scaffolds were fabricated using 3D printing technology.
[0042] The specific synthesis method is as follows:
[0043] (1) To prepare Zn-doped HA with a molar ratio of [Zn / (Zn+Ca)] of 10% (denoted as 10Zn@HA), Ca(NO3)2, Zn(NO3)2, and Na2HPO4 were added to 150 mL of deionized water in sequence while maintaining the molar ratio of (Ca+Zn) / P in the solution at 1.67. 2+ The threshold concentration is low. High concentrations of zinc may cause toxicity once degraded. Literature shows that about 0-5nmol / L is usually harmless to cells. The 10% Zn in this article is about 1.538nmol / L, which is within the usable range.
[0044] (2) In order to prepare Zn / Mg-doped HA with molar ratios of [Zn / (Zn+Mg+Ca)=10%] and [Mg / (Zn+Mg+Ca)=5% / 10% / 15%] (denoted as 5Mg10Zn@HA, 10Mg10Zn@HA, and 15Mg10Zn@HA, respectively), Ca(NO3)2, Zn(NO3)2, Mg(NO3)3, and Na2HPO4 were added sequentially into 150 mL of deionized water while maintaining the molar ratio of (Ca+Zn+Mg) / P in the solution at 1.67.
[0045] (3) The prepared solutions were all subjected to magnetic stirring to make Ca 2+ The concentration was 0.1 M. Then, the pH of the mixture was adjusted to 2.3 with acid, and H6L was added (final concentration of the solution was 1 mM). After H6L was completely dissolved, urea was added (final concentration of the solution was 0.56 M) until it was completely dissolved.
[0046] (4) Then, the prepared solution was transferred to a six-station polytetrafluoroethylene automatic autoclave (Xi'an Xiantaikang, China) for reaction (200°C, 12 hours), and the precipitate was collected after the reaction. The obtained precipitate was washed by centrifugation (4000 rpm, 3 minutes), and then repeatedly washed with deionized water and anhydrous ethanol until the pH value reached neutral, and dried in an oven (65°C, 48 hours). Undoped HA was also prepared in the same way.
[0047] (5) 4.5 g PCL was dissolved in 40 ml dichloromethane and stirred thoroughly. Then 0.5 g HA, 10Zn@HA, 5Mg10Zn@HA, 10Mg10Zn@HA and 15Mg10Zn@HA powders were dispersed in 40 mL of the solution and stirred thoroughly for 3 h to form a uniform "ink". The prepared "ink" was extruded through a 23G (0.33 mm) conical plastic nozzle at a speed of 5 mm / s and a pressure of 0.2 MPa to obtain a porous three-dimensional scaffold. Finally, the 3D-printed HA-PCL, 10Zn@HA-PCL, 5Mg10Zn@HA-PCL, 10Mg10Zn@HA-PCL and 15Mg10Zn@HA-PCL scaffolds were freeze-dried for 24 h (condenser temperature: -69.9 °C, sample temperature: -56.8 °C, vacuum degree: 0.5 Pa) to remove the organic solvent.
[0048] (6) Scanning electron microscopy (SEM), energy dispersive spectroscopy (EDS), X-ray diffraction (XRD) and Fourier transform infrared spectroscopy (FTIR) were used to observe the material morphology and test the molecular structure of the Zn / Mg co-doped composite scaffold material. Figure 2 , 3 shown.
[0049] Depend on Figure 2 It can be seen that the scanning electron microscopy (SEM) results ( Figure 2 A) shows that all groups of HA are spherical with a diameter of 5 to 10 μm. Compared with HA synthesized without H6L, the addition of H6L makes HA uniformly spherical. The spherical shape and particle size of element-doped HA are consistent with those of HA, indicating that element doping has no significant effect on the morphology of HA by H6L. In addition, energy dispersive spectroscopy (EDS) ( Figure 2 A) shows that all groups contain Ca and P. 10Zn@HA, 5Mg10Zn@HA, 10Mg10Zn@HA, 15Mg10Zn@HA groups contain Zn element, 5Mg10Zn@HA, 10Mg10Zn@HA and 15Mg10Zn@HA groups contain Mg element, while 10Zn@HA group does not contain Mg element. All elements are evenly distributed on the HA surface, indicating that the synthesis of Zn and Mg doped HA is successful. X-ray diffraction analysis shows that ( Figure 2B), the element-doped HA maintains the hydroxyapatite structure. The addition of H6L slows down the growth rate of HA crystals on the a-axis and weakens the preferential growth trend on the c-axis, forming a spherical structure. After doping with Zn, the growth trend of HA crystals in all directions weakens, forming an irregular spherical structure. The addition of Mg slows down the growth of HA crystals on the a-axis, weakens the preferential growth trend on the c-axis, and forms a spherical structure. The morphology of HA can be controlled by adjusting the amount of H6L and doping elements. And Fourier transform infrared spectroscopy (FTIR) analysis shows ( Figure 2 C), element-doped HA has characteristic functional group peaks of hydroxyapatite. 3700-2500cm -1 The broad peak at 1639 cm represents the HO stretching vibration peak of free water molecules adsorbed on the surface of the material. -1 The peak represents its bending vibration peak. 3- The bending and stretching vibration peaks appear at 564 and 602 cm -1 and 958, 1034, 1108cm -1 CO3 also exists in synthetic HA and element-doped HA 2- CO bonds at 872 and 1416 cm -1 and 1453cm -1 The peak at represents PO4 3- and OH-site A and B CO3 2- The OH characteristic peak of OH- was not obvious, which further confirmed the A-type and B-type carbonate substitution. Carbonated apatite has better biocompatibility and does not affect the biological efficacy.
[0050] Depend on Figure 3 It can be seen that the scanning electron microscopy (SEM) results ( Figure 3 A) showed that all composite scaffolds exhibited a uniform and interconnected three-dimensional porous structure with a pore size of about 300 μm, which can promote cell migration and nutrient transport, and promote capillary formation and new bone formation. In addition, the cross-section of 15Mg10Zn@HA-PCLs was circular and regular with a diameter of about 400 μm. EDS results showed that the elements Ca, P, Zn, and Mg were evenly distributed in the scaffold, indicating that the synthesized HA and PCL were evenly mixed ( Figure 3 B). Mechanical strength evaluation shows ( Figure 3 C), there was no significant difference in the elastic modulus of the scaffolds in each group ( Figure 3 D).
[0051] Example 2
[0052] Evaluation of in vitro angiogenesis ability of 3D printed composite scaffolds
[0053] (1) Preparation of composite scaffold extracts
[0054] The composite scaffolds were soaked in 75% ethanol solution for 30 minutes, and then washed with sterile PBS three times, each time for 10 minutes. Then, α-MEM and DMEM culture media were added at a concentration of 10 mg / mL, respectively, and real-time extraction was performed in a sterile environment at 37°C, and fresh complete culture medium was used every other day to generate composite scaffold extracts in real time.
[0055] (2) Effect of composite scaffolds on HUVECs cell proliferation
[0056] The experimental groups were set as: Control, HA-PCLs, 10Zn@HA-PCLs, 5Mg10Zn@HA-PCLs, 10Mg10Zn@HA-PCLs and 15Mg10Zn@HA-PCLs
[0057] (3) CCK-8 test: HUVECs were cultured at 3×10 3 The cells were uniformly inoculated into 96-well culture plates at a density of 1 / well. After the cells adhered to the wall, they were replaced with the corresponding composite scaffold extract according to the experimental group and continued to be cultured in a 37°C, 5% CO2 incubator. At 24h, 48h and 72h, the culture medium was removed, 10μL CCK-8 reagent was added after washing with PBS, and the cells were continued to be incubated in the incubator for 1h. Then, the absorbance at 450nm was detected by an ELISA instrument to detect the effect of each group of composite scaffold materials on the survival and proliferation of HUVEC cells. The results are shown in Figure 4 shown.
[0058] (4) Live and dead staining: HUVEC cells were plated at 1×10 5 / well were evenly inoculated in a 6-well confocal culture plate. After the cells adhered to the wall, they were replaced with the corresponding composite scaffold extract according to the experimental grouping and continued to be cultured. After 72 hours, the culture medium was aspirated and washed with PBS, and then 300μL 4% paraformaldehyde was added to fix the cells for 20 minutes, and then washed with PBS three times. Calcein-AM / PI cell live and dead staining working solution was prepared, and 200μL of the working solution was added to each well, incubated for 30 minutes, and then washed with PBS three times, and the live and dead staining of HUVEC cells was observed under a laser confocal microscope. The results are shown in Figure 4 shown.
[0059] (5) Wound healing experiment: HUVEC cells were cultured at 1×10 5The cells were evenly inoculated at a density of 100 μg / well in a 6-well culture plate and placed in a cell culture incubator for 24 h. After the cells adhered to the wall, they were scratched with a pipette tip and washed with PBS to remove the scratched cells. The corresponding composite scaffold extract was added according to the experimental grouping. This time was recorded as "0 h" and placed in an incubator for continued culture. Then, after 12 h and 24 h of co-culture, the same position was observed under a microscope and photographed and recorded. The results are shown in Figure 2. Figure 4 shown.
[0060] (6) The Bio-Rad real-time quantitative reverse transcription-polymerase chain reaction (RT-qPCR) system was used to detect the expression of angiogenesis-related genes VEGF, VEGFR1 (FLT1), VEGFR2 (KDR), and bFGF. GAPDH was used as the internal reference gene during the detection process, and the 2-ΔΔCT method was used to obtain the relative expression data. The results are shown in Figure 4 shown.
[0061] Depend on Figure 4 As shown. CCK-8 experiment shows ( Figure 4 A), Mg / Zn dual-doped scaffolds have the best effect on promoting HUVECs proliferation, and with the increase of Mg 2+ As the concentration increased, the cell proliferation effect was enhanced. After 72 hours, the number of cells in the 15Mg10Zn@HA-PCLs group was significantly higher than that in the 5Mg10Zn@HA-PCLs group. In addition, after 72 hours of co-culture, live / dead cell staining showed that almost all HUVECs were alive (green fluorescence), with very few dead cells (red fluorescence), and the number of cells in the dual-element doping group was greater than that in the other three groups. The results were consistent with those of CCK-8, indicating that all scaffolds had good cell compatibility ( Figure 4 C). Wound healing experiments showed that ( Figure 4 B, 4D), the scaffolds containing Mg can more effectively promote the migration of HUVECs, and the 10Mg10Zn@HA-PCLs and 15Mg10Zn@HA-PCLs groups have the best effect. At the same time, we detected the expression of angiogenesis-related genes VEGF, VEGFR1 (FLT1), VEGFR2 (KDR) and bFGF ( Figure 4 E). Contains Mg 2+ The expression levels of these genes in the 10Mg10Zn@HA-PCLs and 15Mg10Zn@HA-PCLs groups were higher than those in the other three groups, and the expression levels in the 10Mg10Zn@HA-PCLs and 15Mg10Zn@HA-PCLs groups were the highest, which was consistent with the results of the wound healing experiment.
[0062] (7) Western blotting was used to detect the expression of angiogenesis-related proteins CD31 and VEGF, and the band signals were statistically analyzed using Image J software. Figure 5 shown.
[0063] Depend on Figure 5 As shown in Figure 2, Western blot analysis confirmed that the Mg-doped group showed stronger expression of CD31 and VEGF compared with the pure Zn-doped group, and the expression levels increased with the increase of Mg 2+ The results showed that Mg 2+ It can promote the proliferation and migration of HUVECs.
[0064] Example 3
[0065] Evaluation of the osteogenic differentiation potential of 3D printed composite scaffolds in vitro
[0066] (1) CCK-8 test: BMSCs were cultured at 5×10 3 The cells were evenly inoculated into a 96-well culture plate at a density of 10 μg / well. After the cells adhered to the wall, they were replaced with the corresponding composite scaffold extract according to the experimental grouping and continued to be cultured in a 37°C, 5% CO2 incubator, with the medium changed every two days. On the 1st, 3rd and 5th days, the culture medium was removed, 10 μL CCK-8 solution was added after washing with PBS, and the cells were continued to be incubated in the incubator for 1 hour. Then, the absorbance at 450 nm was detected with an ELISA reader to detect the proliferation activity of BMSCs in each group. The results are shown in Figure 6 shown.
[0067] (2) Live-dead staining: BMSCs were plated at 1×10 5 / well were evenly seeded in a 6-well confocal culture plate. After the cells adhered to the wall, they were replaced with the corresponding composite scaffold extract according to the experimental groups and continued to be cultured. On the 3rd day, the culture medium was aspirated and washed with PBS, and then 300μL 4% paraformaldehyde was added to fix the cells for 20 minutes, and then washed with PBS three times. Calcein-AM / PI cell live and dead staining working solution was prepared, and 200μL of the working solution was added to each well, incubated for 30 minutes, and then washed with PBS three times, and the live and dead staining of BMSCs was observed under a laser confocal microscope. The results are shown in Figure 6 shown.
[0068] Depend on Figure 6 As shown in the figure, the CCK-8 experiment showed that after the composite scaffold extract was co-cultured with BMSCs for 1 day, 3 days and 5 days, there was no significant difference in cell viability between each group and the control group on the first day. As time went on, all groups promoted the proliferation of BMSCs, and the effect of the Mg / Zn element doping group was more significant ( Figure 6 After 72 hours of co-culture, live / dead cell staining showed no obvious dead cells in all samples ( Figure 6 B).
[0069] (3) Alkaline Phosphatase (ALP) staining: BMSCs were plated at 2×104 / well were seeded in a 12-well plate, cultured for 24 hours until the cells adhered to the wall, and then replaced with the corresponding composite scaffold extract according to the experimental grouping and continued to culture. The liquid was changed every 2 days for 14 days. On the 7th and 14th days, the culture medium was aspirated, and the cells were washed 3 times with PBS, then fixed with 4% paraformaldehyde for 20 minutes, and then washed 3 times with PBS, and the ALP staining working solution was added, and incubated in the dark at room temperature for 20 minutes. After removing the staining working solution, wash twice with distilled water to terminate the color reaction, observe under a microscope and take pictures to record. The results are as follows Figure 7 shown.
[0070] (4) Alizarin Red Staining (ARS) BMSCs were plated at 2×10 4 / well were inoculated in a 12-well plate, cultured for 24 hours until the cells adhered to the wall, and then replaced with the corresponding composite scaffold extract according to the experimental grouping and continued to culture. The liquid was changed every 2 days for 21 days. On the 21st day, the culture medium was aspirated, and the cells were washed 3 times with PBS, then fixed with 4% paraformaldehyde for 20 minutes, and then washed 3 times with PBS, ARS staining working solution was added, and incubated in the dark at room temperature for 20 minutes. After removing the staining working solution, wash twice with distilled water to terminate the color reaction, observe under a microscope and take pictures to record. The results are as follows Figure 7 shown.
[0071] (5) The Bio-Rad real-time quantitative reverse transcription-polymerase chain reaction (RT-qPCR) system was used to detect the expression of osteogenesis-related genes OPN, OCN, ALP, and RUNX2. GAPDH was used as the internal reference gene during the detection process, and the 2-ΔΔCT method was used to obtain the relative expression data. Figure 7 shown.
[0072] Depend on Figure 7 It can be seen that alkaline phosphatase (ALP) staining ( Figure 7 A), the results showed that the ALP staining area of the doped element group was larger than that of the control group and the HA-PCLs group. In addition, the ALP staining area of the Mg / Zn dual-doped group was larger than that of the single Zn doped group, and with the increase of Mg 2+ The staining area increased with the increase of concentration, while there was no significant difference between the 10Mg10Zn@HA-PCLs group and the 15Mg10Zn@HA-PCLs group, which is consistent with the results of quantitative analysis of ALP activity ( Figure 7 C). After 21 days of in vitro induction, Alizarin Red S (ARS) staining was performed to evaluate the effect of the composite scaffold on the late mineralization ability of BMSCs. The results showed that the formation of mineralized nodules in the Mg / Zn dual-doped group was greater than that in the other three groups, and with the increase of Mg ion doping concentration, the formation of mineralized nodules also increased ( Figure 7B). Quantitative results ( Figure 7 D) showed that the mineral deposition in the 15Mg10Zn@HA-PCLs group was the highest, which was consistent with the ARS staining results. These results indicate that the Mg / Zn dual-doped composite scaffold can promote the osteogenic differentiation of bone marrow mesenchymal stem cells, and the differentiation effect is better with the increase of Mg ion doping concentration. qPCR results ( Figure 7 E) showed that the expression levels of OPN, OCN, ALP and RUNX2 in the Mg / Zn dual-doped group were higher than those in the control group and were positively correlated with the Mg doping concentration. The expression level in the 15Mg10Zn@HA-PCLs group was the highest, which was consistent with the ALP and ARS staining and quantification results.
[0073] (6) Western blotting was used to detect the expression of osteogenic-related proteins OPN, OCN, and COL1A1, and the band signals were statistically analyzed using Image J software. Figure 8 shown.
[0074] Depend on Figure 8 It can be seen that the Western blot results showed that the expression levels of OPN, OCN and COL1 in the Mg / Zn dual-doped group were higher than those in the control group, which was consistent with the qPCR results.
[0075] Example 4
[0076] Evaluation of the osteogenic differentiation potential of 3D printed composite scaffolds in vivo
[0077] The rat femoral defect model was used to evaluate the ability of the composite scaffold to promote bone repair. H&E and Masson staining were used to evaluate bone regeneration after 1 month and 3 months of treatment with the composite scaffold. Fig. 9 As shown in the figure, H&E results showed that new bone was formed in all groups. However, the Zn-doped group and the Zn / Mg co-doped group were better than the control group and the HA group. New bone appeared around the scaffold (the blank area is the scaffold), and the formation of new bone increased with the increase of Mg doping. At the same time, Masson staining analysis further confirmed that Zn 2+ and Mg 2+ The co-doping of Zn@HA-PCLs promoted the formation of new bone. The 10Mg10Zn@HA-PCLs group and the 15Mg10Zn@HA-PCLs group were the darkest and widest areas (blue and red represent collagen synthesis and new bone formation), indicating more calcification and bone maturation. Related studies have shown that Zn 2+ It has osteogenic and antibacterial activity. However, excessive zinc concentration may cause toxicity in vivo, which is a potential safety hazard. Therefore, this study used Zn 2+ The sustained release method ensures its safe release in the body. 2+The addition of can synergistically promote the growth of blood vessels and the formation of new bones. The above results show that the composite scaffold material has good cell compatibility, and can promote the proliferation of HUVEC cells and BMSCs to differentiate into angiogenic and osteogenic cells, has good angiogenic and osteogenic functions, and can effectively repair critical size bone defects caused by trauma, bone tumors, infection and other diseases.
[0078] The above examples illustrate that the Mg element in the composite scaffold material has an angiogenic effect, the Zn element has a bone healing and antibacterial effect, and HA has excellent osteoconduction and osteoinduction properties. The addition of 1,2,3,4,5,6-cyclohexanehexacarboxylic acid monohydrate (H6L) small molecule template agent makes the synthesized HA into microspheres with uniform sphericity and regular morphology. Finally, polycaprolactone (PCL) that can maintain the scaffold morphology and mechanical properties is mixed as an ink, and a Zn / Mg co-doped composite scaffold material is prepared by 3D printing, thereby effectively repairing critical-sized bone defects caused by diseases such as trauma, bone tumors, and infections, providing a theoretical and practical basis for the clinical application and transformation of Zn / Mg co-doped composite scaffold materials in repairing critical-sized bone defects.
[0079] The above embodiments show and describe the basic principles, main features and advantages of the present invention. Those skilled in the art should understand that the above embodiments do not limit the present invention in any form, and any technical solution obtained by equivalent replacement or equivalent transformation falls within the protection scope of the present invention.
Claims
1. A method for preparing a composite material for repairing critical size bone defects, characterized in that: The following steps are involved: 1) Ca(NO3)2, Zn(NO3)2, Mg(NO3)3 and Na2HPO4 are added into deionized water and dissolved completely so that the molar ratio of (Ca+Zn+Mg) / P in the solution is 1-2; 2) adjusting the pH of the solution in step 1) to between 2 and 3 with an acid, and then adding an appropriate amount of 1,2,3,4,5,6-cyclohexanehexacarboxylic acid monohydrate H6L. After H6L is completely dissolved, adding urea until it is completely dissolved; 3) transferring the solution prepared in step 2) to a reactor for reaction at a temperature of 150-250° C. for 10-14 hours, collecting the precipitate after the reaction, washing the precipitate by centrifugation, and then repeatedly washing it with deionized water and anhydrous ethanol until the pH value reaches neutral, and drying it in an oven to obtain a powder; 4) dissolving an appropriate amount of PCL in dichloromethane and stirring thoroughly, then dispersing the powder obtained in step 3) in the dichloromethane and stirring to form a uniform dispersion; The composite material for repairing critical-size bone defects is obtained.
2. The method for preparing a composite material for repairing critical size bone defects according to claim 1, characterized in that: In the step 1), the molar ratio of Mg:(Zn+Mg+Ca) is 0.05-0.
15.
3. The method for preparing a composite material for repairing critical size bone defects according to claim 1, characterized in that: In the step 1), the molar ratio of Zn:(Zn+Mg+Ca) is less than 0.3, preferably 0.
1.
4. The method for preparing a composite material for repairing critical size bone defects according to claim 1, characterized in that: In the step 1), stirring is performed, and the solution finally Ca 2+ The concentration is 0.05-0.2M.
5. The method for preparing a composite material for repairing critical size bone defects according to claim 1, characterized in that: The final concentration of H6L in the solution in step 2) is 0.5-2 mM.
6. The method for preparing a composite material for repairing critical size bone defects according to claim 1, characterized in that: The final concentration of urea in the solution in step 2) is 0.5-0.6M.
7. The method for preparing a composite material for repairing critical size bone defects according to claim 1, characterized in that: The following steps are involved: 1) Add Ca(NO3)2, Zn(NO3)2, Mg(NO3)3 and Na2HPO4 into 150 mL of deionized water and dissolve completely to obtain a mixed solution; the molar ratio of (Ca+Zn+Mg) / P in the solution is 1.67, the molar ratio of Mg:(Zn+Mg+Ca) is 0.05-0.15, and the molar ratio of Zn:(Zn+Mg+Ca) is 0.1; Ca 2+ The concentration is 0.1M; 2) The pH of the mixed solution was adjusted to 2.3 with acid, and H6L was added to a final concentration of 1 mM. After H6L was completely dissolved, urea was added to a final concentration of 0.56 M and dissolved; 3) transferring the solution prepared in step 2) to a six-station polytetrafluoroethylene automatic autoclave for reaction at 200° C. for 12 h, centrifuging at 4000 rpm for 3 min after the reaction, collecting the precipitate, washing the obtained precipitate, and then repeatedly washing it with deionized water and anhydrous ethanol until the pH value reaches neutral, and drying it in an oven to obtain a powder; 4) Dissolve 4.5 g of PCL in 40 ml of dichloromethane and stir thoroughly, then disperse 0.5 g of the powder prepared in step 3) in the dichloromethane solution and stir thoroughly to obtain the composite material for repairing critical size bone defects.
8. A composite material for repairing critical size bone defects, characterized in that: The invention is prepared by the preparation method according to any one of claims 1 to 7.
9. Use of the composite material for repairing critical size bone defects according to claim 8 in preparing a three-dimensional scaffold, characterized in that: The following steps are involved: The prepared composite material is extruded through a 0.1-1 mm conical plastic nozzle at a speed of 1-10 mm / s and a pressure of 0.1-0.3 MPa to obtain a porous three-dimensional scaffold; the scaffold is freeze-dried to remove the organic solvent.
Citation Information
Cited By
Preparation and application of self-piezoelectric aluminum nitride film / cavity assembly structure for promoting large-section critical bone defect repair
CN120884744A
Preparation and application of self-piezoelectric aluminum nitride film / cavity assembly structure for promoting repair of large segment critical bone defects
CN120884744B
